ChickenStockChickenStock

AI English summary of an SEC filing — figures as filed

IDEXX Laboratories logoIDEXX Laboratories IDXX

IDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. IDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.

  2. The company said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation to provide shareholders owning at least 25% of the shares of the Corporation's capital stock continuously for at least 1 year the right to have the Corporation call a special meeting of shareholders, subject to additional terms, conditions, limitations and procedures as set forth in the Corporation's By-Laws.

  3. IDEXX Laboratories said a Certificate of Amendment reflecting the approved amendments was filed with the Secretary of State of the State of Delaware and became effective on May 13, 2026, and the Corporation's By-Laws were amended and restated effective upon the filing of the Certificate of Amendment on the same date.

  4. The company disclosed that on the shareholder proposal to give shareholders the ability to call for a special shareholder meeting, voting results were 28,179,566 for, 40,019,951 against and 227,294 abstentions, and on the proposal to amend the Certificate of Incorporation to provide shareholders owning 25% of the shares the right to call a special meeting, voting results were 63,934,239 for.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Board declassification amendment approved

IDEXX Laboratories said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation at the annual meeting held on May 12, 2026 to declassify the Board over 3 years and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders.

Source · Based on the filing body and exhibits

Special meeting call right amendment approved

The company said shareholders approved amendments to the Corporation's Amended and Restated Certificate of Incorporation to provide shareholders owning at least 25% of the shares of the Corporation's capital stock continuously for at least 1 year the right to have the Corporation call a special meeting of shareholders, subject to additional terms, conditions, limitations and procedures as set forth in the Corporation's By-Laws.

Source · Based on the filing body and exhibits

Certificate amendment effective; By-Laws amended

IDEXX Laboratories said a Certificate of Amendment reflecting the approved amendments was filed with the Secretary of State of the State of Delaware and became effective on May 13, 2026, and the Corporation's By-Laws were amended and restated effective upon the filing of the Certificate of Amendment on the same date.

Source · Based on the filing body and exhibits

Shareholder proposal and special meeting call right voting results

The company disclosed that on the shareholder proposal to give shareholders the ability to call for a special shareholder meeting, voting results were 28,179,566 for, 40,019,951 against and 227,294 abstentions, and on the proposal to amend the Certificate of Incorporation to provide shareholders owning 25% of the shares the right to call a special meeting, voting results were 63,934,239 for.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.